Evidence map›Paper›PMID 42350604›Full record

ArticleLeukemia2026

Role of endothelial Dlc1 in embryonic vascular development and adult bone marrow hematopoiesis.

Jing-Xin Feng, Marian E Durkin, Mei-Ting Yang, Lili Li, Ross Lake, Caiyi Li, Ferenc Livak, Lino Tessarollo, Michael Kruhlak, Douglas R Lowy and 1 more

Abstract read
In one paragraph

Article in Leukemia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jing-Xin FengLaboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health, Bethesda, MD, USA.ORCID http://orcid.org/0000-0003-0677-2792
Marian E DurkinLaboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health, Bethesda, MD, USA.ORCID http://orcid.org/0000-0002-0005-8806
Mei-Ting YangExperimental Immunology Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health, Bethesda, MD, USA.
Lili LiLaboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health, Bethesda, MD, USA.
Ross LakeLCBG Microscopy Core, Laboratory of Cancer Biology and Genetics, CCR/NCI/NIH, Bethesda, MD, USA.
Caiyi LiFlow Cytometry Core, Laboratory of Genome Integrity, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health, Bethesda, MD, USA.
Ferenc LivakFlow Cytometry Facility, Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA, USA.
Lino TessarolloNeural Development Section, Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute (NCI), NIH, Frederick, MD, USA.
Michael KruhlakCenter for Cancer Research Microscopy Core, Laboratory of Cancer Biology and Genetics, NCI, NIH, Bethesda, MD, USA.ORCID http://orcid.org/0000-0003-3976-6233
Douglas R LowyLaboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health, Bethesda, MD, USA.
Giovanna TosatoLaboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health, Bethesda, MD, USA. tosatog@mail.nih.gov.ORCID http://orcid.org/0000-0003-1663-3227

Funding

Study of the Roles of SDF1 and CXCR4 in HematopoiesisZIABC010782 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI TOSATO, GIOVANNA · 2009 to 2025
$10.2M
Intramural NIH HHS ZIA BC010782
6 · The paper itself

Abstract

Bone marrow endothelial cells (ECs) form specialized vascular niches that support hematopoietic stem and progenitor cells (HSPC), yet the molecular regulators of this function remain incompletely defined. Here, we identify the Rho GTPase-activating protein Dlc1 as an essential regulator of developmental vasculogenesis, and adult bone marrow vascular niche integrity. Endothelial-specific deletion of Dlc1 caused embryonic lethality with severe vascular defects. In adult mice, inducible EC-specific Dlc1 deletion disrupted the bone marrow vascular architecture, associated with a significant reduction of multipotent hematopoietic progenitors and myeloid-lineage cells. Single-cell RNA sequencing revealed transcriptional reprogramming of Dlc1-deficient ECs, with the emergence of cell subsets displaying altered transcriptional profiles and disrupted expression of key niche signals, including Kitl, Cxcl12, and Pdgfb. Ligand-receptor interactome analysis demonstrated impaired EC-to-HSPC communication, and the hematopoietic cells exhibited transcriptional features of metabolic stress and reduced biosynthetic activity. These findings position Dlc1 as a central regulator of developmental vasculogenesis, adult vascular architecture in the bone marrow, and EC-derived hematopoietic cell support. This work uncovers a previously unrecognized role for Dlc1 in coupling vessel function to hematopoietic cell output, with implications for understanding bone marrow failure syndromes and targeting endothelial dysfunction in hematologic diseases.

Indexed as

AngiogenesisBone MarrowEmbryonic DevelopmentEndothelial CellsGTPase-Activating ProteinsHematopoiesisNeovascularization, PhysiologicTumor Suppressor ProteinsAnimalsHematopoietic Stem CellsHumansMiceStem Cell NicheGTPase-Activating ProteinsTumor Suppressor Proteins

Identifiers

PMID42350604
PMCPMC13421314

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.